As of 2025-10-18, the Relative Valuation of NGM Biopharmaceuticals Inc (NGM) is (34.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.54 USD, the upside of NGM Biopharmaceuticals Inc based on Relative Valuation is -2332.2%.
The range of the Relative Valuation is (17.98) - (58.58) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 34.4x | 18.2x |
| Forward P/E multiples | 10.5x - 34.3x | 22.1x |
| Fair Price | (17.98) - (58.58) | (34.38) |
| Upside | -1267.6% - -3904.1% | -2332.2% |
| Date | P/E |